PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
08-Sep-2021 Next-Generation Nano-, Capillary- and Micro-Flow LC Systems Enhance Productivity and Performance Thermo Fisher Scientific
08-Sep-2021 New Lonza Webinar – “An Automated Integrated QC Laboratory – MODA-EM® Software & Growth Direct® System” Lonza Group AG
08-Sep-2021 New Mass Spectrometry Portfolio Leverages Enhanced Hardware and Software to Advance Quantitative Analysis Thermo Fisher Scientific
08-Sep-2021 Cannovum AG expands Supervisory Board and Medical Advisory Board Cannovum AG
08-Sep-2021 Original-Research: HAEMATO AG (von First Berlin Equity Research GmbH) HAEMATO AG
08-Sep-2021 Single Use Support Providing Solutions for Gene Therapies Single Use Support
08-Sep-2021 Relief Therapeutics to Participate in the H.C. Wainwright 23rd Annual Global Investment Conference RELIEF THERAPEUTICS Holdings AG
07-Sep-2021 Community Wellness Announces COVID Home Management Program Community Wellness
07-Sep-2021 ENPICOM introduces a powerful liability prediction solution to de-risk antibody development ENPICOM
07-Sep-2021 Cherwell Laboratories to highlight developments of ImpactAir® range at the Cleanroom Technology Conference 2021 Cherwell Laboratories
07-Sep-2021 Cyted continues rapid expansion and shares new growth programme Cyted
07-Sep-2021 Pharma.Aero Published a White paper on the Use of Unmanned Aerial Vehicles (UAV) in the Pharma & Humanitarian Air Cargo Sectors Pharma.Aero
07-Sep-2021 EnteroBiotix Raises over $21m in Series A Financing to Advance its Microbiome Drug Pipeline EnteroBiotix
07-Sep-2021 Takeda to Manufacture and Provide 150 Million Doses of Novavax’ COVID-19 Vaccine Candidate to the Government of Japan Takeda
07-Sep-2021 Pfizer and BioNTech Submit a Variation to EMA with the Data in Support of a Booster Dose of COMIRNATY® Pfizer and BioNTech
07-Sep-2021 Roche to present data from industry leading portfolio at ESMO 2021 showing significant progress in early stage and uncommon cancers Roche
07-Sep-2021 DEFENCE THERAPEUTICS DEVELOPMENT PROGRAM TO ENGINEER A NEW HPV VACCINE INITIATED Defence Therapeutics Inc.
07-Sep-2021 Dermapharm Holding SE publishes H1 2021 report, confirms outlook for 2021 overall Dermapharm Holding SE
07-Sep-2021 Heidelberg Pharma Provides Update on Phase I/IIa Clinical Trial with ATAC Candidate HDP-101 in the US Heidelberg Pharma AG
07-Sep-2021 Relief Therapeutics Comments on Certain Statements Made by NRx Pharmaceuticals in its Registration Statement on Form S-1 Filed on September 3, 2021 RELIEF THERAPEUTICS Holdings AG